Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Conceptus Inc Stories

2013-06-05 04:20:49

-- 96.4 percent of Conceptus' shares tendered LEVERKUSEN, Germany and WAYNE, N.J., June 5, 2013 /PRNewswire/ -- The Bayer Group has successfully completed its tender offer for the outstanding shares of Conceptus, Inc., Mountain View, California (NASDAQ: CPTS). As of the expiration of the offer period last night, 31,983,536 shares were validly tendered and not withdrawn in the tender offer, representing approximately 96.4 percent of the currently outstanding shares - including...

2013-05-29 04:20:42

Offer expires at midnight on June 4/5, 2013 LEVERKUSEN, Germany and WAYNE, N.J., May 29, 2013 /PRNewswire/ -- Antitrust clearance from the US Federal Trade Commission (FTC) was obtained with respect to Bayer's acquisition of Conceptus, Inc., Mountain View, California (NASDAQ:CPTS). The FTC raised no objection to the transaction within the relevant waiting period under US antitrust law, which expired yesterday. The antitrust clearance marks an important step toward Bayer's intended...

2013-05-07 16:30:05

LEVERKUSEN, Germany and WAYNE, N.J., May 7, 2013 /PRNewswire/ -- Bayer's planned acquisition of Conceptus, Inc., based in Mountain View, California (NASDAQ: CPTS) is entering its next phase: Evelyn Acquisition Company, a subsidiary established by Bayer HealthCare LLC, Tarrytown, N.Y., for the purpose of the acquisition, is commencing today a cash tender offer for all the shares of Conceptus, Inc. at a price of US$31.00 per share. The total value of the transaction amounts to...

2013-04-30 12:27:37

WAYNE, Pa., April 30, 2013 /PRNewswire/ -- Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/cpts) is investigating potential claims against the board of directors of Conceptus, Inc. ("Conceptus" or the "Company") (NASDAQ: CPTS) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to Bayer HealthCare LLC, a subgroup of Bayer AG, in an all-cash deal valued at about $1.1 billion. Our investigation concerns possible...

2013-04-29 04:21:08

Adds Essure®, the only non-surgical permanent birth control method, to Bayer's contraception portfolio WAYNE, N.J. and MOUNTAIN VIEW, Calif., April 29, 2013 /PRNewswire/ -- Bayer intends to broaden its portfolio in the field of contraception. Thus, Bayer HealthCare LLC has signed a merger agreement with Conceptus, Inc. (NASDAQ:CPTS), the California-based developer of the Essure(®) procedure, the leading non-surgical permanent birth control method, which is sold in the United...

2012-01-09 12:30:00

BEDFORD, Mass., Jan. 9, 2012 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that Conceptus, Inc.'s (Conceptus) request for an injunction barring future sales of Hologic's Adiana permanent contraception (Adiana) system has been denied and that no royalty will be due to Conceptus...

2011-09-22 12:00:00

RED BANK, N.J., Sept. 22, 2011 /PRNewswire/ -- In preparation for World Contraception Day, HealthyWomen, the nation's leading independent health information source for women, released a nationwide survey of women that explores an issue faced by most couples at some point in their relationship: How do they know when they are done having children and what contraception will they use to avoid an unplanned pregnancy? The survey, conducted by Harris Interactive of 1,006 women showed that a...

2011-01-10 10:39:00

Permanent Contraception in Ghana, Kenya, Mexico, Puerto Rico, and Turkey CHAPEL HILL, N.C., Jan. 10, 2011 /PRNewswire-USNewswire/ -- WomanCare Global is pleased to announce an expansion of their product portfolio to include Essure®, a non-surgical permanent birth control and the most effective permanent contraceptive method on the market. WomanCare Global will provide full sales, marketing, training and distribution of Essure in Ghana, Kenya, Mexico, Puerto Rico and...

58f75d21da57d5a7c91ee49bba4ca7ac
2009-04-08 09:01:45

Trista Sutter, former star of the U.S. reality TV series The Bachelorette, announced plans Wednesday to undergo a permanent birth control procedure. Sutter said she and her husband Ryan believe their family is complete with the birth last week of their daughter Blakesley Grace. The couple also has a son Maxwell Alston, who was born July 26, 2007. By choosing the Essure procedure, Trista will avoid the added pain and recovery time of getting her tubes tied combined with her C-section,...

2009-04-08 07:11:00

Trista Sutter, the Original Bachelorette, Decides Her Family is Complete After the Birth of Her Second Child VAIL, Colo., April 8 /PRNewswire/ -- After the arrival of her second child (a baby girl named Blakesley Grace born on April 3, 2009), Trista Sutter, the star of ABC's first Bachelorette show, has announced that with two healthy children, this will be the last child for the couple. Trista plans to get the Essure(R) permanent birth control procedure. (Photo:...